SINTEF AS (SINTEF AS)

SINTEF (established in 1950, head office in Trondheim, Norway, approx.. 2000 employees, annual sales of 400M€, customers in 61 countries) is one of the largest non-profit independent research organization in Europe. SINTEF is a multidisciplinary organization performing contract research and development in the fields of health, medical technology, information and communications technology, marine activities, materials science and applied chemistry, petroleum and energy, technology management and building construction for a wide range of Norwegian and international industry customers. SINTEF promotes open innovation processes; interaction between different stakeholders is of high importance. SINTEF participates as a research partner in publicly funded research projects, both at the national and to a large extent at the EU level. SINTEF Industry, Department of Biotechnology and Nanomedicine has various technology platforms and specialized infrastructure for nanoparticle-based diagnosis and therapy, and is a core partner in the European Nanomedicine Characterisation Laboratory (EU-NCL) which provides preclinical safety data for novel and candidate European nanomedicines by offering advanced characterization services.

Address

Strindveien 4
7034 Trondheim
Norway

Website

https://www.sintef.no

Dr Ruth Schmid

Principal investigator

Ruth Schmid is Vice President Marketing at SINTEF Materials and Chemistry, Department of Biotechnology and Nanomedicine, in Trondheim with special responsibility for the area of medical technology, including nanomedicine. She gained her Diploma (1975) and PhD (1979) in Natural Sciences at ETH Zürich, Switzerland. Her present research activities include the preparation and characterisation of micro- and nanoparticles, as well as the surface modification of polymers and polymer particles for applications in nanomedicine and various other industrial segments.

Sven Even Borgos

Deputy principal investigator

Sven Even Borgos holds a diploma (2000) degree in mathematics and medical physics, and a PhD (2006) in molecular genetics, obtained at the Norwegian University of Science and Technology (NTNU). He is working as senior research scientist at SINTEF Materials and Chemistry, Dept. of Biotechnology and Nanomedicine. His field of specialty is advanced analytical chemistry, mainly based on mass spectrometry (MS) and adjacent separation sciences (chromatography, field flow fractionation). He has particular interest in the analysis of nanoparticles, including nanomedicines, and MS chemical imaging.

Eurice